Thursday, May 26, 2016

Ionis shares slump 40 pct as GSK scraps heart drug trial plans

May 26 (Reuters) - Ionis Pharmaceuticals Inc's

shares plunged 40 percent on Thursday, wiping out over $900

million from its market value, after the company said

GlaxoSmithKline Plc had scrapped...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)